- Report
- July 2022
- 255 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- October 2022
- 177 Pages
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- October 2022
- 174 Pages
North America
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- October 2022
- 181 Pages
Middle East, Africa
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- October 2022
- 202 Pages
Europe
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 90 Pages
South Korea
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Indonesia
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
India
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 90 Pages
France
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Russia
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Mexico
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Germany
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Canada
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Italy
From €4567EUR$4,750USD£3,918GBP
Novolog is a brand of insulin used to treat diabetes, a condition in which the body does not produce or properly use insulin. It is a fast-acting insulin that helps to control blood sugar levels. Novolog belongs to a class of drugs known as endocrine and metabolic disorders drugs, which are used to treat a variety of conditions related to hormones and metabolism. These drugs work by either increasing or decreasing the production of hormones or by altering the way the body uses them.
Novolog is used to treat both type 1 and type 2 diabetes. It is typically taken before meals to help control blood sugar levels. It can also be used in combination with other diabetes medications. Novolog is available in both injectable and inhalable forms.
The Novolog market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and AstraZeneca. Show Less Read more